Literature DB >> 25223451

Anticoagulant therapy: Rivaroxaban for patients with AF undergoing cardioversion.

Gregory B Lim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25223451     DOI: 10.1038/nrcardio.2014.151

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.

Authors:  Riccardo Cappato; Michael D Ezekowitz; Allan L Klein; A John Camm; Chang-Sheng Ma; Jean-Yves Le Heuzey; Mario Talajic; Maurício Scanavacca; Panos E Vardas; Paulus Kirchhof; Melanie Hemmrich; Vivian Lanius; Isabelle Ling Meng; Peter Wildgoose; Martin van Eickels; Stefan H Hohnloser
Journal:  Eur Heart J       Date:  2014-09-02       Impact factor: 29.983

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.